| Literature DB >> 24367618 |
Johan A Snoek1, Sietske van Berkel1, Nico van Meeteren2, Frank J G Backx3, Hein A M Daanen4.
Abstract
BACKGROUND: Although a delayed decrease in heart rate during the first minute after graded exercise has been identified as a powerful predictor of overall mortality in cardiac patients, the potential to influence this risk factor by aerobic training remains to be proven.Entities:
Mesh:
Year: 2013 PMID: 24367618 PMCID: PMC3867471 DOI: 10.1371/journal.pone.0083907
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Description of search.
Selection of trials investigating heart rate recovery.
Overview of (quasi) Randomized Controlled Trials included in the review.
| Author | Study population | Groups | Participants (n)per group | Stress test | Measure-ment HRR | Type of training | Frequency + length of training | Intensity of training | Length of rehab. | Change HRR (60 sec) |
|---|---|---|---|---|---|---|---|---|---|---|
| Giallauria | STEMI | 2 | 37,38 | Bicycle | 60 sec | Cycling | E: 3 x p.w. 40 min C: untrained | 60-70 % peak VO2 | 26 wk | E: 13 → 20* C: 14 → 12* |
| Legramante | CABG | 2 | 43,39 | Bicycle | 60 sec + other | Cycling | E: 6 x p.w. 2 x p.d 30 min C: untrained | 75-85 % HR max | 2 wk | E: 8 → 12 C: 7 → 10 |
| Moholdt | AMI | 2 | 59,30 | Treadmill | 60 sec | Treadmill vs W+J+L+S | E: 3 x p.w. 38 min C: 3 x p.w. 60 min | E: 85-95 % HR max C: Vigorous exercise | 12 wk | E: 31 → 33 C: 33 → 34 |
| Myers | CHF | 2 | 12,12 | Bicycle | 60 sec + other | Cycling Walking | E: 4 x p.w. 45 min + 2 x p.d. 60 min C: usual care | E: 60-80 % HR reserve | 8 wk | E: 8 → 14 C: 9 → 10 |
| Ribeiro | CAD | 2 | 20,18 | Treadmill | 60 sec | Aerobic exercise | E: 3 x p.w. 55 min C: usual care | 65-75 % HR max | 8 wk | E: 20 → 24* C: 26 → 26* |
| Tsai | CABG | 2 | 15,15 | Bicycle | 60 sec | Cycling; Walking | E: 3 x p.w. 30-40 min C: No cardiac rehabilitation | 60-80 % HR max | 12 wk | E: 4 → 16* C: 5 → 11* |
| Wu | CABG | 3 | 18,18,18 | Bicycle | 60 sec | Cycling; Treadmill | E: 3 x p.w. 50-80 min Eh: 3 x p.w. 50-80 min C: No exercise | 60-85 % HR max | 12 wk | E: 9 → 19* Eh: 8 → 16 C: 9 → 14* |
| Zeng | AMI | 2 | 27,30 | Bicycle | 60 sec | Cycling | E: 3 x p.w. 30 min C: No exercise | AT | 26 wk | E: 12 → 17* C: 12 → 12* |
Abbreviations: n (number); Change HRR (Change in Heart Rate Recovery from begin- to endpoint); STEMI (ST Elevated Myocardial Infarction); CABG (Coronary Artery Bypass Graft); AMI (Acute Myocardial Infarction);W+J+L+S (Walking, Jogging, Lunges, Squats); CHF (Chronic Heart Failure); CAD (Coronary Artery Disease); E (Exercise group); Eh (Exercise at home group); C (Control group); VO2 (oxygen uptake); HR (Heart Rate); AT (Anaerobic Threshold) * Significant (p<0.05) between group difference
Assessment of risk of bias per individual study per scale item.
| Blinding | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Adequate randomi-sation | Allocation concealed | Patient | Care provider | Outcome assessor | Drop-out rate described | Intention to treat analysis | Groups similar at baseline | Co inter-ventions avoided | Compliance acceptable | Timing of outcome assessment similar | Total score |
| Giallauria | Yes | Unsure | No | Unsure | Yes | Yes | Yes | Yes | No | Yes | Yes | 7 (64%) |
| Legramente | Unsure | Unsure | No | Unsure | Unsure | Yes | Yes | Yes | Yes | Unsure | Yes | 5 (46%) |
| Moholdt | Yes | Yes | No | Unsure | Unsure | Yes | Yes | Yes | Yes | Yes | Yes | 8 (73%) |
| Myers | Unsure | Unsure | No | Unsure | Unsure | Yes | Yes | Yes | No | Unsure | Yes | 4 (36%) |
| Ribeiro | Yes | Yes | No | Unsure | Unsure | Yes | Yes | No | Yes | Unsure | Yes | 6 (55%) |
| Tsai | Yes | Yes | No | Unsure | Unsure | Yes | Yes | Yes | Yes | Unsure | Yes | 7 (64%) |
| Wu | Yes | Unsure | Yes | Unsure | Yes | Yes | Yes | Yes | Yes | Unsure | Yes | 8 (73%) |
| Zeng | No | No | No | Unsure | Unsure | Yes | Yes | Yes | Yes | Unsure | Yes | 5 (46%) |
| Total score | 5 (63%) | 3 (38%) | 1 13%) | 0 (0%) | 2 (25%) | 8 (100%) | 8 (100%) | 7 (88%) | 6 (75%) | 2 (25%) | 8 (100%) |
Assessment of therapeutic validity per individual study per scale item (CONTENT scale).
| Patient eligibility | Rationale | Content | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Described | Adequate | Setting and therapist | Study | Intervention | Intensity | Monitored | Personalized | Adherence | Total score | |
| Giallauria | yes | yes | no | yes | no | yes | no | yes | yes | 6 (66%) | |
| Legramente | yes | no | no | yes | no | yes | no | no | no | 3 (33%) | |
| Moholdt | yes | yes | no | yes | no | yes | no | no | yes | 5 (55%) | |
| Myers | yes | yes | yes | yes | no | yes | no | yes | no | 6 (66%) | |
| Ribeiro | yes | yes | no | yes | yes | yes | no | no | no | 5 (55%) | |
| Tsai | no | yes | no | yes | no | yes | no | no | no | 3 (33%) | |
| Wu | yes | yes | yes | yes | no | yes | no | yes | no | 6 (66%) | |
| Zeng | yes | yes | no | yes | no | no | no | no | no | 3 (33%) | |
| Total score | 7 (88%) | 7 (88%) | 2 (25%) | 8 (100%) | 1 (13%) | 7 (88%) | 0 (0%) | 3 (38%) | 2 (25%) | ||
Methodological and therapeutic validity scores per study.
|
|
|
|
|---|---|---|
| Giallauria et al. (2011) | 7 (64%) | 6 (66%) |
| Legramante | 5 (46%) | 3 (33%) |
| Moholdt | 8 (73%) | 5 (55%) |
| Myers | 4 (36%) | 6 (66%) |
| Ribeiro | 6 (55%) | 5 (55%) |
| Tsai | 7 (64%) | 3 (33%) |
| Wu | 8 (73%) | 6 (66%) |
| Zeng | 5 (46%) | 3 (33%) |
* Significant (p<0.05) between group difference
** Low risk of bias and a high therapeutical validity